BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 23028188)

  • 1. Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer.
    Liang H; Cheung LW; Li J; Ju Z; Yu S; Stemke-Hale K; Dogruluk T; Lu Y; Liu X; Gu C; Guo W; Scherer SE; Carter H; Westin SN; Dyer MD; Verhaak RG; Zhang F; Karchin R; Liu CG; Lu KH; Broaddus RR; Scott KL; Hennessy BT; Mills GB
    Genome Res; 2012 Nov; 22(11):2120-9. PubMed ID: 23028188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of novel mutations in endometrial cancer patients by whole-exome sequencing.
    Chang YS; Huang HD; Yeh KT; Chang JG
    Int J Oncol; 2017 May; 50(5):1778-1784. PubMed ID: 28339086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic mutation profiles of clear cell endometrial tumors revealed by whole exome and targeted gene sequencing.
    Le Gallo M; Rudd ML; Urick ME; Hansen NF; Zhang S; ; Lozy F; Sgroi DC; Vidal Bel A; Matias-Guiu X; Broaddus RR; Lu KH; Levine DA; Mutch DG; Goodfellow PJ; Salvesen HB; Mullikin JC; Bell DW
    Cancer; 2017 Sep; 123(17):3261-3268. PubMed ID: 28485815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next-Generation Sequencing.
    Le Gallo M; Lozy F; Bell DW
    Adv Exp Med Biol; 2017; 943():119-148. PubMed ID: 27910067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic Analysis of Uterine Lavage Fluid Detects Early Endometrial Cancers and Reveals a Prevalent Landscape of Driver Mutations in Women without Histopathologic Evidence of Cancer: A Prospective Cross-Sectional Study.
    Nair N; Camacho-Vanegas O; Rykunov D; Dashkoff M; Camacho SC; Schumacher CA; Irish JC; Harkins TT; Freeman E; Garcia I; Pereira E; Kendall S; Belfer R; Kalir T; Sebra R; Reva B; Dottino P; Martignetti JA
    PLoS Med; 2016 Dec; 13(12):e1002206. PubMed ID: 28027320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution and heterogeneity of non-hereditary colorectal cancer revealed by single-cell exome sequencing.
    Wu H; Zhang XY; Hu Z; Hou Q; Zhang H; Li Y; Li S; Yue J; Jiang Z; Weissman SM; Pan X; Ju BG; Wu S
    Oncogene; 2017 May; 36(20):2857-2867. PubMed ID: 27941887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exome sequencing of oral squamous cell carcinoma in users of Arabian snuff reveals novel candidates for driver genes.
    Al-Hebshi NN; Li S; Nasher AT; El-Setouhy M; Alsanosi R; Blancato J; Loffredo C
    Int J Cancer; 2016 Jul; 139(2):363-72. PubMed ID: 26934577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis.
    Gibson WJ; Hoivik EA; Halle MK; Taylor-Weiner A; Cherniack AD; Berg A; Holst F; Zack TI; Werner HM; Staby KM; Rosenberg M; Stefansson IM; Kusonmano K; Chevalier A; Mauland KK; Trovik J; Krakstad C; Giannakis M; Hodis E; Woie K; Bjorge L; Vintermyr OK; Wala JA; Lawrence MS; Getz G; Carter SL; Beroukhim R; Salvesen HB
    Nat Genet; 2016 Aug; 48(8):848-55. PubMed ID: 27348297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exome-wide Sequencing Shows Low Mutation Rates and Identifies Novel Mutated Genes in Seminomas.
    Cutcutache I; Suzuki Y; Tan IB; Ramgopal S; Zhang S; Ramnarayanan K; Gan A; Lee HH; Tay ST; Ooi A; Ong CK; Bolthouse JT; Lane BR; Anema JG; Kahnoski RJ; Tan P; Teh BT; Rozen SG
    Eur Urol; 2015 Jul; 68(1):77-83. PubMed ID: 25597018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-exome sequencing reveals recurrent somatic mutation networks in cancer.
    Liu X; Wang J; Chen L
    Cancer Lett; 2013 Nov; 340(2):270-6. PubMed ID: 23153794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes.
    Le Gallo M; O'Hara AJ; Rudd ML; Urick ME; Hansen NF; O'Neil NJ; Price JC; Zhang S; England BM; Godwin AK; Sgroi DC; ; Hieter P; Mullikin JC; Merino MJ; Bell DW
    Nat Genet; 2012 Dec; 44(12):1310-5. PubMed ID: 23104009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PIK3CA cooperates with other phosphatidylinositol 3'-kinase pathway mutations to effect oncogenic transformation.
    Oda K; Okada J; Timmerman L; Rodriguez-Viciana P; Stokoe D; Shoji K; Taketani Y; Kuramoto H; Knight ZA; Shokat KM; McCormick F
    Cancer Res; 2008 Oct; 68(19):8127-36. PubMed ID: 18829572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic mutations in histologically normal endometrium: the new normal?
    Lac V; Nazeran TM; Tessier-Cloutier B; Aguirre-Hernandez R; Albert A; Lum A; Khattra J; Praetorius T; Mason M; Chiu D; Köbel M; Yong PJ; Gilks BC; Anglesio MS; Huntsman DG
    J Pathol; 2019 Oct; 249(2):173-181. PubMed ID: 31187483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of new driver and passenger mutations within APOBEC-induced hotspot mutations in bladder cancer.
    Shi MJ; Meng XY; Fontugne J; Chen CL; Radvanyi F; Bernard-Pierrot I
    Genome Med; 2020 Sep; 12(1):85. PubMed ID: 32988402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ARID1A gene mutation in ovarian and endometrial cancers (Review).
    Takeda T; Banno K; Okawa R; Yanokura M; Iijima M; Irie-Kunitomi H; Nakamura K; Iida M; Adachi M; Umene K; Nogami Y; Masuda K; Kobayashi Y; Tominaga E; Aoki D
    Oncol Rep; 2016 Feb; 35(2):607-13. PubMed ID: 26572704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of somatic mutation, expression and functional data reveals potential driver genes predictive of breast cancer survival.
    Suo C; Hrydziuszko O; Lee D; Pramana S; Saputra D; Joshi H; Calza S; Pawitan Y
    Bioinformatics; 2015 Aug; 31(16):2607-13. PubMed ID: 25810432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exomes of Ductal Luminal Breast Cancer Patients from Southwest Colombia: Gene Mutational Profile and Related Expression Alterations.
    Cortes-Urrea C; Bueno-Gutiérrez F; Solarte M; Guevara-Burbano M; Tobar-Tosse F; Vélez-Varela PE; Bonilla JC; Barreto G; Velasco-Medina J; Moreno PA; Rivas JL
    Biomolecules; 2020 Apr; 10(5):. PubMed ID: 32365829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying Candidate Druggable Targets in Canine Cancer Cell Lines Using Whole-Exome Sequencing.
    Das S; Idate R; Cronise KE; Gustafson DL; Duval DL
    Mol Cancer Ther; 2019 Aug; 18(8):1460-1471. PubMed ID: 31175136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers in the endometrium.
    Berchuck A
    J Cell Biochem Suppl; 1995; 23():174-8. PubMed ID: 8747393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ARID1A and PI3-kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion.
    Wilson MR; Reske JJ; Holladay J; Wilber GE; Rhodes M; Koeman J; Adams M; Johnson B; Su RW; Joshi NR; Patterson AL; Shen H; Leach RE; Teixeira JM; Fazleabas AT; Chandler RL
    Nat Commun; 2019 Aug; 10(1):3554. PubMed ID: 31391455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.